EP3439498B1 - Chaussure à usage post-chirurgical - Google Patents

Chaussure à usage post-chirurgical Download PDF

Info

Publication number
EP3439498B1
EP3439498B1 EP17727692.0A EP17727692A EP3439498B1 EP 3439498 B1 EP3439498 B1 EP 3439498B1 EP 17727692 A EP17727692 A EP 17727692A EP 3439498 B1 EP3439498 B1 EP 3439498B1
Authority
EP
European Patent Office
Prior art keywords
shoe
kit according
insole
thickness
front portion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP17727692.0A
Other languages
German (de)
English (en)
Other versions
EP3439498A1 (fr
Inventor
Enrico BUZIOL
Stefano FIESCHI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP3439498A1 publication Critical patent/EP3439498A1/fr
Application granted granted Critical
Publication of EP3439498B1 publication Critical patent/EP3439498B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A43—FOOTWEAR
    • A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
    • A43B13/00—Soles; Sole-and-heel integral units
    • A43B13/02—Soles; Sole-and-heel integral units characterised by the material
    • A43B13/04—Plastics, rubber or vulcanised fibre
    • A—HUMAN NECESSITIES
    • A43—FOOTWEAR
    • A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
    • A43B11/00—Footwear with arrangements to facilitate putting-on or removing, e.g. with straps
    • A—HUMAN NECESSITIES
    • A43—FOOTWEAR
    • A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
    • A43B13/00—Soles; Sole-and-heel integral units
    • A43B13/02—Soles; Sole-and-heel integral units characterised by the material
    • A43B13/12—Soles with several layers of different materials
    • A—HUMAN NECESSITIES
    • A43—FOOTWEAR
    • A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
    • A43B13/00—Soles; Sole-and-heel integral units
    • A43B13/02—Soles; Sole-and-heel integral units characterised by the material
    • A43B13/12—Soles with several layers of different materials
    • A43B13/125—Soles with several layers of different materials characterised by the midsole or middle layer
    • A—HUMAN NECESSITIES
    • A43—FOOTWEAR
    • A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
    • A43B13/00—Soles; Sole-and-heel integral units
    • A43B13/14—Soles; Sole-and-heel integral units characterised by the constructive form
    • A43B13/18—Resilient soles
    • A43B13/187—Resiliency achieved by the features of the material, e.g. foam, non liquid materials
    • A43B13/188—Differential cushioning regions
    • A—HUMAN NECESSITIES
    • A43—FOOTWEAR
    • A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
    • A43B17/00—Insoles for insertion, e.g. footbeds or inlays, for attachment to the shoe after the upper has been joined
    • A—HUMAN NECESSITIES
    • A43—FOOTWEAR
    • A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
    • A43B7/00—Footwear with health or hygienic arrangements
    • A43B7/14—Footwear with health or hygienic arrangements with foot-supporting parts
    • A43B7/1405—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form
    • A43B7/1455—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form with special properties
    • A43B7/147—Footwear with health or hygienic arrangements with foot-supporting parts with pads or holes on one or more locations, or having an anatomical or curved form with special properties for sick or disabled persons, e.g. persons having osteoarthritis or diabetes
    • A—HUMAN NECESSITIES
    • A43—FOOTWEAR
    • A43B—CHARACTERISTIC FEATURES OF FOOTWEAR; PARTS OF FOOTWEAR
    • A43B7/00—Footwear with health or hygienic arrangements
    • A43B7/14—Footwear with health or hygienic arrangements with foot-supporting parts
    • A43B7/28—Adapting the inner sole or the side of the upper of the shoe to the sole of the foot
    • A—HUMAN NECESSITIES
    • A43—FOOTWEAR
    • A43C—FASTENINGS OR ATTACHMENTS OF FOOTWEAR; LACES IN GENERAL
    • A43C11/00—Other fastenings specially adapted for shoes
    • A43C11/008—Combined fastenings, e.g. to accelerate undoing or fastening
    • A—HUMAN NECESSITIES
    • A43—FOOTWEAR
    • A43C—FASTENINGS OR ATTACHMENTS OF FOOTWEAR; LACES IN GENERAL
    • A43C11/00—Other fastenings specially adapted for shoes
    • A43C11/12—Slide or glide fastenings

Definitions

  • the present invention relates to a kit for the making of a rehabilitation aid adapted to be worn by a patient in the post-operative period following surgery to the foot, such as "hallux valgus" surgery.
  • Known shoes specific to this type of application are usually of the sandal type, or open as they are more easily adaptable to the swollen and bandaged foot as one that just had surgery. In general, they have Velcro fastenings, to be easily wearable and an oversized vamp and sole with respect to traditional shoes, precisely in order to be worn with swollen and bandaged foot.
  • known shoes are worn only on the foot that has undergone surgery. Therefore, they are unilateral, that is, the patient wears a standard shoe on the healthy foot. This implies bad posture and an incorrect and uncomfortable walking, with obvious inconvenience to the patient.
  • known shoes have a substantially stiff sole structure, they only have a support function, and therefore are not adapted for walking.
  • the object of the present invention therefore is to solve the problems just set forth above.
  • a further object is to provide a shoe that can be reused even after rehabilitation. This feature is particularly beneficial in economic terms for the patient, who buys a shoe not strictly aimed for the specific rehabilitation time, but a shoe that can be reused over time, thus amortising the costs thereof.
  • the invention consists of a kit for the creation of an aid for the rehabilitation of the foot in the post-surgery period, and in particular in the hallux valgus post-surgery period.
  • the aid consists of an orthopedic shoe which in turn comprises an vamp 1 and a sole 2 ( figure 4 ).
  • the sole is concealed by a side coating band 3 which lines and then covers the connection between sole and vamp.
  • the vamp 1 comprises a main portion 1a on which a front portion 10 is defined.
  • Front portion 10 is anteriorly integral along a transversal connecting line 100 to the main portion of the vamp; the front portion also defines side edges 101 extending substantially parallel to each other and perpendicular to the connecting line, in longitudinal position or according to a longitudinal direction defined between the tip, corresponding to the area of the shoe worn by the forefoot and the heel of the shoe, which is the area of the shoe worn by the heel of the foot (by transverse direction, in contrast, it is meant that perpendicular to such a longitudinal direction).
  • Reversible connecting means 11 rest on such side edges 101, such as, preferably but not limited to, zippers, to allow the connection or detachment of the front portion to/from the main portion of the vamp, or the lifting thereof along the transversal connecting line 100.
  • the front portion 10 can be fully connected to the main portion of the vamp (for example, in the preferred embodiment when the zippers are open), thus completing the profile of the shoe, or detached therefrom (always with reference to the preferred embodiment when the zippers are closed) so as to be lifted along the front connecting portion to the main portion of the vamp.
  • the complete detachment of the front portion facilitates wearing the shoe also with swollen and/or bandaged foot.
  • the front portion 10 is also advantageously made in such a way as to be enlarged or narrowed transversally by acting on relative adjustment means 12.
  • the front portion can consist of two separate parts mutually connected lengthwise by means of the above adjustment means.
  • the front portion 10 consists of two separate parts mutually connected by means of said adjustment means in the form of a lacing, according to a solution of known type in sneakers or tennis shoes. By tightening the lacing more or less, the shoe adapts to the various stages of foot swelling/bandage for the duration of the post-surgery period.
  • this consists of a first layer comprising a rubber tread 20 that defines the resting surface of the shoe on the ground (for example with knurling to prevent slipping or the like).
  • a rubber tread 20 that defines the resting surface of the shoe on the ground (for example with knurling to prevent slipping or the like).
  • a midsole 21 shown alone in figure 7 .
  • Tread 20 is connected to vamp 1 and the midsole 21 by vulcanisation, according to devices known in the field of athletic shoes.
  • the connection area between the rubber tread and the vamp is then covered by the above side coating band 3.
  • Midsole 21 instead defines, with an upper surface thereof, the foot support when the shoe is worn.
  • the midsole consists of a felt matrix 210 on which an insert 211 of a shape memory material (such as polyethylene) is inserted. This insert is positioned in the forefoot area.
  • a shape memory material such as polyethylene
  • the aid also comprises a first and a second orthopedic insole.
  • Figures 5 and 6 schematically show the shoe and the placement of any orthopedic insole, which is depicted schematically, therefore not taking into account of the actual sizes or proportions with respect to the midsole or the tread.
  • the first orthopedic insole 4 ( figure 8a ) has an evenly decreasing thickness between a maximum thickness in the heel area and a minimum thickness in the forefoot area.
  • the maximum thickness in the heel area ranging from 1.0 to 2.0 cm (with a preferred value of 1.5 cm) and the minimum thickness in the forefoot area ranging from 0.3 to 0.7 cm (with a preferred value of 0.5 cm).
  • the second orthopedic insole 5 ( figure 8b ) has an evenly decreasing thickness between a maximum thickness in the heel area and a minimum thickness in the forefoot area.
  • the maximum thickness in the heel area is between 2 and 3 cm (with a preferred value of 2.5 cm) and the minimum thickness in the forefoot area is between 0.8 and 1.8 cm (with a preferred value of 1.5 cm).
  • the first 4 and the second insole 5 are made for example of, but not limited to, polyethylene.
  • the patient soon after surgery wears on the healthy foot (not subjected to surgery) a shoe according to the invention with the first orthopedic insole, while on the foot subjected to surgery he/she will wear the show without orthopedic insole.
  • Wearing a shoe with the first orthopedic insole 4 on the foot that did not have surgery determines that the foot has a slightly sloping posture (due to the difference in thickness between the heel and forefoot of the first orthopedic insole) and this position of the foot that did not have surgery favours walking with the foot that had surgery.
  • the first orthopedic insole 4 is removed from both shoes and replaced by the second orthopedic insole 5 which, being higher than the first orthopedic insole, will favour the standard walking and the traditional fit, walking, comparable to that of any sneaker.
  • the shoes can then be worn and used also when the foot that had surgery has healed, as traditional sneakers.
  • the aid just described is therefore particularly advantageous; in particular, the shoe can be worn even in the first few days after surgery and then throughout the post-surgery period.
  • This advantage is achieved also due to the possibility of using the two insoles 4, 5 with very different sizes; normally in a shoe one can use a single orthopedic insole with relatively small thickness variation, while in the invention the difference in thickness of the orthopedic insoles is more than one centimetre in the heel and more than 5 mm at the front.
  • the above vamp structure obtains a variable fit of the shoe on the user's foot by adjusting the size of the front portion through the adjustment means. Moreover, due to the presence of the front portion that can be detached from the rest of the vamp, the shoe can be easily worn or removed from the foot, particularly important feature in the case of swollen or bandaged feet typical of the post-surgery period.
  • vulcanised rubber outer sole and midsole (not known in the vulcanisation process for common sneakers) imparts elasticity and softness to the shoe.
  • This technology which is derived from the field of athletic shoes, has never been used for post-surgery orthopedic shoes for the hallux valgus pathology.
  • the midsole made of felt and the insert made of shape memory material is light and provides better shock absorption compared to a conventional rubber midsole.
  • the shape memory material in particular, supports the foot and keeps memory of the support thereof so as to provide more elasticity to the bottom structure of the shoe.
  • the shoe as a whole is therefore particularly lightweight and thus comfortable for the patient in the post-surgery phase but also absolutely comfortable and adapted to support and absorb walking shocks, making the patient have a painless or generally non annoying walk.
  • the aid as a whole is therefore also adapted to allow walking directly in the post-sutgery phase.
  • the shoe provided with suitable alternation of the two orthopedic insoles or alone, can be worn from the time just after the surgery and for the entire post-surgery period, on both feet, thus obtaining not only a saving in terms of money (the patient is not forced to buy new shoes after a first recovery period when the foot is less swollen) but also in terms of comfort, as wearing the same type of shoe on both feet involves a more correct and balanced walking and distribution of the body weight with an undeniable benefit for the back, pelvis and legs.
  • the patient also has a greater psychological well-being, since he/she can immediately wear a pair of shoes totally similar in appearance to those he/she usually wears; this is due to the vamp on a vulcanised sole, a typical aesthetic aspect of a pair of sneakers.
  • the shoe can be worn immediately after surgery, when the foot is swollen with the use of the first shoerter orthopedic insole 4 (achieving a greater shoe size); when the foot is not swollen any more, with the continuation of the healing phase, adding the second orthopedic insole 5 the shoe takes a normal fit.
  • the shoe may be considered innovative even individually.
  • the presence of the rubber tread 20 attached to vamp by vulcanisation and midsole 21 superimposed inside the tread, where the midsole comprises the felt matrix and insert 211 made of a shape memory material at the front of the shoe, intended to be the worn by the forefoot, represent features of the shoe that make it innovative even per se.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Footwear And Its Accessory, Manufacturing Method And Apparatuses (AREA)

Claims (12)

  1. Kit pour la réalisation d'une aide à la rééducation pour la période post-opératoire de l'hallux valgus, comprenant une chaussure comprenant une empeigne (1) et une semelle (2), ladite empeigne comprenant une partie principale (1a) et une partie avant (10), ladite partie avant (10) faisant saillie depuis ladite partie principale le long d'une ligne de connexion (100), ladite partie avant définissant des bords latéraux (101) sensiblement parallèles entre eux et perpendiculaires à ladite ligne de connexion, lesdits bords étant disposés en position longitudinale, i.e. s'étendant selon une direction longitudinale définie sur la longueur de ladite chaussure, ladite semelle (2) étant une semelle vulcanisée, dans lequel ledit kit comprend en outre une première semelle intérieure (4) pouvant être associée de façon amovible à ladite chaussure, ledit kit étant caractérisé en ce que chacun desdits bords latéraux (101) est associé à des moyens de liaison réversible (11) adaptés pour la connexion réversible et/ou le détachement entre ladite partie avant (10) et ladite partie principale (1a) et en ce qu'il comprend en outre une seconde semelle intérieure (5) pouvant être associée de façon amovible à ladite chaussure, chacune desdites semelles intérieures ayant une épaisseur régulièrement décroissante entre un maximum d'épaisseur dans la zone du talon et un minimum d'épaisseur dans la zone avant du pied, dans lequel la première semelle intérieure et la seconde semelle intérieure ont différentes épaisseurs, dans lequel la différence d'épaisseur entre les première et seconde semelles intérieures est supérieure à 1 cm dans la zone du talon et supérieure à 5 mm dans la zone avant du pied.
  2. Kit selon la revendication 1, dans lequel ladite première semelle intérieure (4) a ladite épaisseur maximale dans la zone du talon allant de 1,0 à 2,0 cm, et ladite épaisseur minimale dans la zone avant du pied allant de 0,3 à 0,7 cm.
  3. Kit selon la revendication 2, dans lequel ladite épaisseur maximale de ladite première semelle intérieure a une valeur préférée de 1,5 cm.
  4. Kit selon l'une des revendications 2 et 3, dans lequel ladite épaisseur minimale de ladite première semelle intérieure a une valeur préférée de 0,5 cm.
  5. Kit selon l'une quelconque des revendications précédentes, dans lequel ladite seconde semelle intérieure (5) a une épaisseur décroissante entre une valeur maximale dans la zone du talon et une valeur minimale dans la zone avant du pied, ladite valeur maximale dans la zone du talon étant comprise entre 2 et 3 cm, ladite valeur minimale dans la zone avant du pied étant comprise entre 0,8 et 1,8 cm.
  6. Kit selon la revendication 5, dans lequel ladite épaisseur maximale de ladite seconde semelle intérieure (5) a une valeur préférée de 2,5 cm.
  7. Kit selon l'une des revendications 5 et 6, dans lequel ladite épaisseur minimale de ladite seconde semelle intérieure a une valeur préférée de 1,5 cm.
  8. Kit selon l'une quelconque des revendications précédentes, dans lequel ladite semelle de ladite chaussure comprend une couche en caoutchouc (20) qui détermine l'assise de la chaussure sur le sol, ladite couche étant reliée à ladite empeigne par vulcanisation.
  9. Kit selon la revendication 8, dans lequel ladite chaussure comprend en outre une semelle intermédiaire (21) reposant sur ladite couche à l'intérieur de ladite chaussure, ladite semelle intermédiaire définissant un support pour le pied lorsque celui-ci porte la chaussure, ladite semelle intermédiaire comprenant une matrice en feutre (210) sur laquelle est ajouté un insert (211) en matériau à mémoire de forme, ledit insert étant placé à l'avant de la chaussure pour être destiné à supporter la partie avant du pied.
  10. Kit selon l'une quelconque des revendications précédentes, dans lequel lesdits moyens de connexion réversible (11) de ladite chaussure comprennent des fermetures à glissière.
  11. Kit selon la revendication 10, dans lequel ladite partie avant (10) de ladite chaussure comprend deux parties séparées reliées entre elles de façon longitudinale par des moyens de réglage (12) par lesquels lesdites deux parties sont rapprochées ou écartées transversalement.
  12. Kit selon la revendication 11, dans lequel lesdits moyens de réglage (12) de ladite chaussure comprennent un lacet qui coopère avec lesdites deux parties de ladite partie avant selon ladite direction longitudinale.
EP17727692.0A 2016-04-05 2017-04-05 Chaussure à usage post-chirurgical Active EP3439498B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITUA2016A002315A ITUA20162315A1 (it) 2016-04-05 2016-04-05 Calzatura post-operatoria
PCT/IB2017/051933 WO2017175141A1 (fr) 2016-04-05 2017-04-05 Chaussure à usage post-chirurgical

Publications (2)

Publication Number Publication Date
EP3439498A1 EP3439498A1 (fr) 2019-02-13
EP3439498B1 true EP3439498B1 (fr) 2020-11-11

Family

ID=56551471

Family Applications (1)

Application Number Title Priority Date Filing Date
EP17727692.0A Active EP3439498B1 (fr) 2016-04-05 2017-04-05 Chaussure à usage post-chirurgical

Country Status (3)

Country Link
EP (1) EP3439498B1 (fr)
IT (1) ITUA20162315A1 (fr)
WO (1) WO2017175141A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4133962A1 (fr) * 2016-11-03 2023-02-15 NIKE Innovate C.V. Fermeture de chaussure à traction rapide
FR3066365B1 (fr) * 2017-05-22 2021-04-30 Implants Service Orthopedie Iso Chaussure
CN107853799A (zh) * 2017-12-29 2018-03-30 施雅雯 一种简便拖鞋
US11849812B2 (en) 2021-09-16 2023-12-26 Canada Goose Inc. Footwear with alternate lacing systems

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB424692A (en) * 1933-10-11 1935-02-27 Patrick James Roche Improvements in shoe fastenings
US3146536A (en) * 1960-02-01 1964-09-01 United Shoe Machinery Corp Premolded outsoles
DE1293651B (fr) * 1965-01-06 1969-04-24
FR2549701A3 (fr) * 1983-07-26 1985-02-01 Humeau Beaupreau Article chaussant du type training
WO2000047073A2 (fr) * 1999-02-08 2000-08-17 Ecco Sko A/S Chaussure pour enfant
US6854199B2 (en) * 2001-09-28 2005-02-15 Joseph Paul Polifroni Layered arch support
US7284342B2 (en) * 2004-08-06 2007-10-23 Schering-Plough Healthcare Products, Inc. Heel insert
US20080235987A1 (en) * 2007-04-02 2008-10-02 Paul Kaufman Footwear Having Removable Attachment-Point Strip
US8151486B2 (en) * 2008-05-20 2012-04-10 Nike, Inc. Fluid-filled chamber with a textile tensile member
EP2358225B1 (fr) * 2008-10-10 2014-05-21 Nike International Ltd. Article de chaussure muni d'une structure de semelle intermediaire
CN102028330A (zh) * 2010-11-29 2011-04-27 张卫 组合式系鞋装置

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
ITUA20162315A1 (it) 2017-10-05
WO2017175141A1 (fr) 2017-10-12
EP3439498A1 (fr) 2019-02-13

Similar Documents

Publication Publication Date Title
EP1209991B1 (fr) Chaussure ou sandale therapeutique
US6298582B1 (en) Article of footwear with heel clip
CA2872811C (fr) Inserts de chaussure a talon haut
EP3439498B1 (fr) Chaussure à usage post-chirurgical
US10299534B2 (en) Midfoot orthotic shoe insert
US20130340281A1 (en) Flexible midfoot orthotic shoe insert
CA2951286A1 (fr) Supports de cheville fonctionnels favorisant le mouvement et le confort
US20180199663A1 (en) Color matched fashionable shoe insert for open shoes device and method
US2182843A (en) Shoe
US20150013181A1 (en) Happy Heelz--An Anatomically Designed Heeled Shoe
KR200462766Y1 (ko) 구두 중창용 허리쇠
US20080178495A1 (en) Foot Clip
CN109330092B (zh) 一种脚踝矫正鞋
US20150335099A1 (en) Memory sneaker
US20090199433A1 (en) Shoe
KR200441275Y1 (ko) 플립플랍형 샌들 및 갑피 덮개형 신발을 조합한 무지외반증 교정화
KR101799939B1 (ko) 신발에 2중 고정되어 발의 통증을 최소화하고 다양한 신발에 적용 가능한 밑창
US20150107001A1 (en) Shoe guard for preventing discomfort and injury
KR101509233B1 (ko) 안전화
CN2433839Y (zh) 一种木屐
Janisse Shoes and shoe modifications
CN212233116U (zh) 一种短袜
KR200343114Y1 (ko) 아킬레스건 신장구
US20240148104A1 (en) Selectively removable insole for high heel shoes
KR20120066135A (ko) 깁스 환자용 신발

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20181010

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20200708

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1332610

Country of ref document: AT

Kind code of ref document: T

Effective date: 20201115

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602017027356

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: PATENTANWAELTE SCHAAD, BALASS, MENZL AND PARTN, CH

REG Reference to a national code

Ref country code: CH

Ref legal event code: PCAR

Free format text: NEW ADDRESS: DUFOURSTRASSE 101, 8034 ZUERICH (CH)

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20201111

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1332610

Country of ref document: AT

Kind code of ref document: T

Effective date: 20201111

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201111

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210212

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201111

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210311

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210211

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201111

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210211

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210311

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201111

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201111

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201111

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201111

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: MT

Payment date: 20210323

Year of fee payment: 5

Ref country code: LU

Payment date: 20210420

Year of fee payment: 5

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201111

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201111

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201111

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201111

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201111

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201111

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: MC

Payment date: 20210422

Year of fee payment: 5

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602017027356

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201111

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20210420

Year of fee payment: 5

Ref country code: IE

Payment date: 20210428

Year of fee payment: 5

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20210812

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201111

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201111

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201111

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201111

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210311

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20220430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220502

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220405

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220430

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220405

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201111

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20170405

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20230403

Year of fee payment: 7

Ref country code: FR

Payment date: 20230424

Year of fee payment: 7

Ref country code: DE

Payment date: 20230420

Year of fee payment: 7

Ref country code: CH

Payment date: 20230502

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20230419

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201111